Clinical Trial: Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5

Brief Summary: The purpose of this project is to study the efficacy of three candidate molecules (Xenbilox, Tahor and Resveratrol) in order to decrease the production of oxysterols by reducing the synthesis of cholesterol and/or regulate the production of bile acids and/or enabling neuroprotective action within the motor neuron.